Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-13 3:33 pm Sale | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | LYTTON LAURENCE W | 0 0% | -521,691 (Position Closed) | View |
| 2023-02-10 09:03 am Sale | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | Samjo Capital LLC | 0 0% | -615,100 (Position Closed) | View |
| 2023-02-03 4:02 pm Unchanged | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | Cowen Prime Advisors LLC | 0 0% | 0 (Unchanged) | View |
| 2022-12-07 06:01 am Sale | 13D | HTG MOLECULAR DIAGNOSTICS INC HTGM | Ault Alliance Inc. AULT | 470,000 4.25% | -330,000 (-41.25%) | View |
| 2022-12-02 4:30 pm Sale | 13D | HTG MOLECULAR DIAGNOSTICS INC HTGM | Ault Alliance Inc. AULT | 800,000 7.24% | -300,000 (-27.27%) | View |
| 2022-08-05 06:01 am Purchase | 13D | HTG MOLECULAR DIAGNOSTICS INC HTGM | Ault Alliance Inc. AULT | 1,100,000 9.96% | 1,100,000 (New Position) | View |
| 2022-07-28 1:06 pm Sale | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | Hewlett Fund LP | 25,000 0.226% | -498,887 (-95.23%) | View |
| 2022-07-18 09:00 am Purchase | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | L5 Capital Inc. | 1,170,000 10.59% | 570,000 (+95.00%) | View |
| 2022-06-29 09:00 am Purchase | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | L5 Capital Inc. | 600,000 5.4% | 600,000 (New Position) | View |
| 2022-03-31 4:05 pm Sale | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | HIRSCHMAN ORIN | 0 0% | -614,000 (Position Closed) | View |
| 2022-02-15 2:16 pm Purchase | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | LYTTON LAURENCE W | 521,691 6.8% | 37,279 (+7.70%) | View |
| 2022-02-14 08:15 am Sale | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | Nantahala Capital Management LLC | 335,015 4.4% | -28,607 (-7.87%) | View |
| 2022-02-11 3:36 pm Purchase | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | HIRSCHMAN ORIN | 614,000 11% | 2,000 (+0.33%) | View |
| 2022-02-09 12:34 pm Purchase | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | Cowen Prime Advisors LLC | 593,133 8% | 593,133 (New Position) | View |
| 2022-02-08 1:57 pm Purchase | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | Samjo Capital LLC | 615,100 8.1% | 615,100 (New Position) | View |
| 2022-01-04 11:30 am Purchase | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | Hewlett Fund LP | 523,887 6.923% | 115,000 (+28.13%) | View |
| 2021-06-30 09:24 am Purchase | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | Hewlett Fund LP | 408,887 5.64% | 408,887 (New Position) | View |
| 2021-06-07 06:22 am Purchase | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | HIRSCHMAN ORIN | 612,000 11% | 612,000 (New Position) | View |
| 2021-02-16 11:37 am Purchase | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | LYTTON LAURENCE W | 484,412 9.99% | 484,412 (New Position) | View |
| 2021-02-16 06:23 am Purchase | 13G | HTG MOLECULAR DIAGNOSTICS INC HTGM | Nantahala Capital Management LLC | 363,622 7.7% | 363,622 (New Position) | View |